Paclibar, Roseminda .
HRN: 27-05-21 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/30/2025
CEFTRIAXONE 1G (VIAL)
04/30/2025
05/06/2025
IVTT
2g
Once A Day
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes